This edition features moat sources in medtech; American cannabis; what eliminating the 1031 would mean for REITs; and notes from newly wide-moat Nvidia and new coverage Sofi and Spirax-Sarco.

This edition features e-commerce after the pandemic; opportunity in salt; trucking demand; and notes from Curaleaf and new coverage Hexcel and AUB Group.

This edition features the future of travel stocks; a year in review for the Wide Moat Focus Index; a legislative lift for cannabis stocks; and notes from Amazon, Google, and Ingredion.

This edition features the year ahead for the coronavirus vaccine; spinal cord stimulation innovation; the Democratic wins in Georgia and the impact on our coverage; and notes from Molson Coors, Intel, and new coverage Exact Sciences.

This edition features digital ad spending outlook; pandemic's impact on payments industry; chipmakers; and notes from Boeing, Amazon, and Curaleaf.

This edition features trouble in the meat aisle; new coverage of a health insurer; Deutsche Boerse's moat upgrade; and notes from Curaleaf, Canadian Natural Resources, and Johnson & Johnson.

This edition features a temperature check of the market amid coronavirus pandemic; cannabis stocks; analysts' purchasing decisions; and notes from Anta Sports, Antero Resources, and new coverage Mapletree Logistics.

Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 19 states, including the assets from the Cura Select and Grassroots acquisitions. Curaleaf offers multiple products under three brands: Curaleaf, Curaleaf Hemp, and UKU Craft Cannabis. The company does not currently export into the global medical market as Canadian cannabis producers typically do.